Research Alliance with Johnson&Johnson
About johnson & johnson innovative medicine
At Johnson & Johnson Innovative Medicine, we are here to transform the future of health. As part of J&J, we work to understand and address the serious health problems of today and unlock the potential medicines of tomorrow. We develop breakthrough treatments, discovering new pathways and modalities to stay in front of diseases, and find cures. Our scientists and researchers are pioneering the path from lab to life and championing patients each step of the way. Our focus areas are: Immunology, Oncology, Neuroscience, Cardiopulmonary, and Specialty Ophthalmology.
About the Oxford-Johnson & Johnson Alliance
The University of Oxford has several strategic collaborations with J&J with programmes in immunology, big data and neuroscience. The aim of the Cartography programme with J&J is to create a detailed cellular atlas across multiple immune-mediated inflammatory disorders (IMIDs). The project will apply the latest molecular and cellular multi-omics analysis platforms and computational methods to deliver insights for target selection and precision medicine for a range of inflammatory disease indications where existing options for therapeutic intervention are limited.
alliance activities
Fellowships
Sponsored research collaborations
Related Links
Therapeutic areas of interest
Immunology
Oncology
Neuroscience
- Specialty Ophthalmology
Alliance Managers
-
Charlotte Bell
Senior Business Partnerships Manager
charlotte.bell@medsci.ox.ac.uk
+44 (0)7711 781932
-
